EcoDrugPlus

Transmembrane O-Methyltransferase Homolog

Ensembl ID : ENSSLDG00000020846
Gene Symbol: LOC111644682
2 Cross references
177 Possible Orthologues:

Transthyretin

Ensembl ID : ENSSLDG00000011681
Gene Symbol: TTR
3 Cross references
178 Possible Orthologues:

Trifunctional Purine Biosynthetic Protein Adenosine-3-Like

Ensembl ID : ENSSLDG00000010632
Gene Symbol: LOC111652198
3 Cross references
245 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSSLDG00000021917
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSSLDG00000016971
Gene Symbol: TUBA1C
4 Cross references
189 Possible Orthologues:

Tubulin Alpha Chain

Ensembl ID : ENSSLDG00000006260
Gene Symbol: LOC111650146
2 Cross references
140 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSSLDG00000009323
Gene Symbol: LOC111671506
3 Cross references
155 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSSLDG00000024710
Gene Symbol: LOC111669889
2 Cross references
205 Possible Orthologues:

Tubulin Beta-1 Chain-Like

Ensembl ID : ENSSLDG00000006820
Gene Symbol: LOC111647788
2 Cross references
95 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSSLDG00000018797
Gene Symbol: LOC111670506
3 Cross references
183 Possible Orthologues:

Tubulin Beta-4b Chain

Ensembl ID : ENSSLDG00000023897
Gene Symbol: LOC111673722
2 Cross references
21 Possible Orthologues:

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSSLDG00000003776
Gene Symbol: LOC111653704
2 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).